Steven Sherman is Executive Chair of EKSO BIONICS HOLDINGS, INC.. Currently has a direct ownership of 456,154 shares of EKSO, which is worth approximately $301,061. The most recent transaction as insider was on Jun 08, 2023, when has been sold 91,241 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 456K
0% 3M change
0% 12M change
Total Value Held $301,061

STEVEN SHERMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 08 2023
BUY
Grant, award, or other acquisition
-
91,241 Added 16.67%
456,154 Common Stock
May 24 2023
SELL
Open market or private sale
$65,750 $1.44 p/Share
45,660 Reduced 11.12%
364,913 Common Stock
Dec 04 2022
SELL
Open market or private sale
$13,537 $1.28 p/Share
10,576 Reduced 1.43%
728,664 Common Stock
Dec 04 2022
BUY
Exercise of conversion of derivative security
-
31,198 Added 4.05%
739,240 Common Stock
Dec 04 2022
BUY
Grant, award, or other acquisition
-
242,679 Added 19.99%
971,343 Common Stock
Nov 21 2022
SELL
Open market or private sale
$7,291 $1.26 p/Share
5,787 Reduced 0.81%
708,042 Common Stock
Nov 21 2022
BUY
Exercise of conversion of derivative security
-
15,599 Added 2.14%
713,829 Common Stock
Oct 24 2022
SELL
Open market or private sale
$7,638 $1.29 p/Share
5,921 Reduced 0.84%
698,230 Common Stock
Oct 21 2022
BUY
Exercise of conversion of derivative security
-
15,600 Added 2.17%
704,151 Common Stock
Sep 22 2022
SELL
Open market or private sale
$10,575 $1.75 p/Share
6,043 Reduced 0.87%
688,551 Common Stock
Sep 21 2022
BUY
Exercise of conversion of derivative security
-
15,599 Added 2.2%
694,594 Common Stock
Aug 22 2022
SELL
Open market or private sale
$12,258 $2.2 p/Share
5,572 Reduced 0.81%
678,995 Common Stock
Aug 21 2022
BUY
Exercise of conversion of derivative security
-
15,599 Added 2.23%
684,567 Common Stock
Jul 25 2022
SELL
Open market or private sale
$9,908 $1.75 p/Share
5,662 Reduced 0.84%
668,968 Common Stock
Jul 21 2022
BUY
Exercise of conversion of derivative security
-
15,599 Added 2.26%
674,630 Common Stock
Jun 22 2022
SELL
Open market or private sale
$9,274 $1.74 p/Share
5,330 Reduced 0.8%
659,031 Common Stock
Jun 21 2022
BUY
Exercise of conversion of derivative security
-
15,599 Added 2.29%
664,361 Common Stock
Jun 15 2022
SELL
Open market or private sale
$13,131 $1.9 p/Share
6,911 Reduced 1.05%
648,762 Common Stock
May 24 2022
SELL
Open market or private sale
$11,611 $1.76 p/Share
6,597 Reduced 1.02%
637,408 Common Stock
May 21 2022
BUY
Exercise of conversion of derivative security
-
15,599 Added 2.36%
644,005 Common Stock
Apr 28 2022
SELL
Open market or private sale
$16,537 $2.41 p/Share
6,862 Reduced 1.08%
628,406 Common Stock
Apr 21 2022
BUY
Exercise of conversion of derivative security
-
15,599 Added 2.4%
635,268 Common Stock
Mar 24 2022
SELL
Open market or private sale
$18,784 $2.94 p/Share
6,389 Reduced 1.02%
619,669 Common Stock
Mar 21 2022
BUY
Exercise of conversion of derivative security
-
15,599 Added 2.43%
626,058 Common Stock
Mar 15 2022
SELL
Open market or private sale
$15,509 $2.6 p/Share
5,965 Reduced 0.97%
610,459 Common Stock
SS

Steven Sherman

Executive Chair
Richmond, CA

Track Institutional and Insider Activities on EKSO

Follow EKSO BIONICS HOLDINGS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EKSO shares.

Notify only if

Insider Trading

Get notified when an Ekso Bionics Holdings, Inc. insider buys or sells EKSO shares.

Notify only if

News

Receive news related to EKSO BIONICS HOLDINGS, INC.

Track Activities on EKSO